Therapeutics / News / PR Newswire / biotechnology / Clinical Trials / Medical Discoveries / Health Care / Hospitals / Medical / Pharmaceuticals / Tradeshow News

Viking Therapeutics Announces Data from In Vivo Study of VK2809 Presented at Oral Plenary Session of the 88th Annual Meeting of American Thyroid Association

Posted on: Oct 8, 2018   |   Posted by: Biotech Mag Top

VK2809 Treatment Leads to Rapid Reduction in Steatosis, Inflammation and Liver Size in Mouse Model of Glycogen Storage Disease Type Ia SAN DIEGO, Oct. 8, 2018 /PRNewswire...